Table 4.
Prevalence of MES (with relative risk) and indicators of cardiovascular risk (split according to gender)
| Male n = 62, (%) | Female n = 77, (%) | Total n, (%) | χ2, P-value* | |
|---|---|---|---|---|
| Metabolic Syndrome present |
19 (31) |
30 (39) |
49 (35) |
NS |
| Relative Risk of Metabolic Syndrome (95% CI, P value)** |
1.737 (1.18-2.54, p < 0.01) |
2.230 (1.67-2.97, p < 0.01) |
2.008 (1.59-2.53, p < 0.01) |
|
| BMI overweight- Hong Kong criterion (≥23) |
48 (77) |
63 (82) |
111 (80) |
NS |
| BMI overweight- International criterion (≥25) |
34 (55) |
45 (58) |
79 (57) |
NS |
| Waist Circumference (males ≥90 cm, females ≥ 80 cm) |
20 (32) |
47 (61) |
67 (48) |
χ2 = 11.40, p < 0.01 |
| Hypertension – Blood pressure ≥ 140/90 |
12 (19) |
21 (27) |
33 (24) |
NS |
| Hypercholesterolemia – Total Cholesterol ≥6.2 mmol/L |
15 (24) |
16 (21) |
31 (22) |
NS |
| Raised LDL cholesterol – LDL ≥ 4.1 mmol/L |
11 (18) |
12 (16) |
23 (16) |
NS |
| Reduced HDL cholesterol – HDL <1.00 mmol/L (males), <1.30 mmol/L (females) |
13 (21) |
19 (25) |
32 (23) |
NS |
| Raised fasting plasma glucose - ≥ 7.00 mmol/L |
8 (13) |
9 (12) |
17 (12) |
NS |
| Raised triglycerides - ≥2.2 mmol/L | 17 (27) | 17 (22) | 34 (25) | NS |
*P for significant differences in cardiovascular risk according to gender, tested by χ2 test.
NS = not statistically significant.
** Data reported by Ko and Tang [6] for the prevalence of MES in the general Hong Kong population was used to calculate the relative risk in this sample.